EUVIMEDEUVIMED entdecken
Open Access

Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS)

Mayra Oliveira, Paige Marquez, Carol Ennulat, Phillip Blanc, Kerry Welsh, Narayan Nair, Monica Taminato, Pedro L Moro

Drug Safety · 2025-03 · 48 (3) · 279-286

DOI: 10.1007/s40264-024-01498-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 12.12.2024. Verfasst von Mayra Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Sao Paulo, R. Napoleão de Barros, 754-Vila Clementino, São Paulo, SP, 04024-002, Brazil. mayrammo@gmail.com. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Product Surveillance, Postmarketing, Pneumococcal Vaccines, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsProduct Surveillance, PostmarketingPneumococcal VaccinesDrug-Related Side Effects and Adverse ReactionsHumansUnited StatesAdultMiddle AgedAgedMaleFemaleYoung AdultUnited States Food and Drug AdministrationGuillain-Barre SyndromeVaccines, ConjugateAged, 80 and over

Substanzen

Pneumococcal VaccinesVaccines, Conjugate

Autor:innen und Institutionen

  • Federal University of Sao Paulo, R. Napoleão de Barros, 754-Vila Clementino, São Paulo, SP, 04024-002, Brazil. mayrammo@gmail.com.
  • Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
  • Federal University of Sao Paulo, R. Napoleão de Barros, 754-Vila Clementino, São Paulo, SP, 04024-002, Brazil.

Förderung

  • Intramural CDC HHS

Zitieren

APA

Oliveira, M., Marquez, P., Ennulat, C., Blanc, P., Welsh, K., Nair, N., Taminato, M., & Moro, P. L. (2025). Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). Drug Safety, 48(3), 279-286. https://doi.org/10.1007/s40264-024-01498-2

Vancouver

Oliveira M, Marquez P, Ennulat C, Blanc P, Welsh K, Nair N, et al. Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). Drug Safety. 2025;48(3):279-286. doi:10.1007/s40264-024-01498-2

BibTeX
@article{Oliveira2025,
  author = {Oliveira, Mayra and Marquez, Paige and Ennulat, Carol and Blanc, Phillip and Welsh, Kerry and Nair, Narayan and Taminato, Monica and Moro, Pedro L},
  title = {Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS)},
  journal = {Drug Safety},
  year = {2025},
  volume = {48},
  number = {3},
  pages = {279--286},
  doi = {10.1007/s40264-024-01498-2}
}
Kostenlos starten →